(34.229.119.176)
Users online: 764    [ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2019, Volume : 12, Issue : 8
First page : ( 3989) Last page : ( 3992)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2019.00687.5

Personalized Medicine-A Review

Kumari P. V. Kamala*, Rao Y. Srinivasa

Vignan Institute of Pharmaceutical Technology, Beside VSEZ, Duvvada, Visakhapatnam

*Corresponding Author E-mail: kamalaparavastu@gmail.com

Online published on 24 December, 2019.

Abstract

Diagnostic and drug research today seeks genomic and molecular-level targeting of cells, tissues, and organs. Often, distinct submolecular mechanisms underlie intended therapeutic and unintended adverse effects that may hold the potential to optimize or, in some cases, revolutionize medical therapeutics. Personalized Medicine offers an opportunity to enhance the value of currently approved drugs with limited market share because of significant toxicity or limited efficacy, enabling prescribers to identify patients for whom they can be both effective and safe. Such recognition of inter individual differences in drug response is an essential step toward optimizing therapy. Individualizing drug therapy raises a number of issues with enormous practical consequences that will be explored further in this series. The dynamic complexity of the human genome, multigenic disease origins, and involvement of numerous genes in drug response impede effective, routine clinical application.

Top

Keywords

Pharmacogenomics, Commercialization.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
598,049,887 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.